Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Veterinary active pharmaceutical ingredients manufacturing are made by more than one reaction from raw materials. It generally becomes an active pharmaceutical ingredients through the chemical compounds. The active pharmaceutical ingredients manufacturing utilize specific standards for determining how strong it is in every drug.
This report aims to provide a comprehensive study of the global market for Veterinary Active Pharmaceutical Ingredients Manufacturing.
Report Highlights:
(1) Global Veterinary Active Pharmaceutical Ingredients Manufacturing market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Veterinary Active Pharmaceutical Ingredients Manufacturing market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Veterinary Active Pharmaceutical Ingredients Manufacturing market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Veterinary Active Pharmaceutical Ingredients Manufacturing segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Veterinary Active Pharmaceutical Ingredients Manufacturing segment by type and by application and regional segment by type and by application.
(6) Veterinary Active Pharmaceutical Ingredients Manufacturing industry supply chain, upstream, midstream and downstream analysis.
According to Latest Research, the global market for Veterinary Active Pharmaceutical Ingredients Manufacturing should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Veterinary Active Pharmaceutical Ingredients Manufacturing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Veterinary Active Pharmaceutical Ingredients Manufacturing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Antiparasitic segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Companion Animals has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing include Alivira Animal Health Ltd., Chempro Pharma Private Ltd., Excel Industries Ltd., FIS - Fabbrica Italiana Sintetici S.p.A., HIKAL Ltd., HuBei Masteam Bio-tech, Hunan Huateng Pharmaceutical, Jiangsu Rivocean and Ofichem Group, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
By Product Type, the market is primarily segmented into:
Antiparasitic
Anti-infectives
NSAIDs
Others
By Applications, the market is segmented into:
Companion Animals
Production/Food Animals
Key Players Driving the Market:
Alivira Animal Health Ltd.
Chempro Pharma Private Ltd.
Excel Industries Ltd.
FIS - Fabbrica Italiana Sintetici S.p.A.
HIKAL Ltd.
HuBei Masteam Bio-tech
Hunan Huateng Pharmaceutical
Jiangsu Rivocean
Ofichem Group
Qilu Pharma Spain, S.A.
Menadiona
Nissan Chemical
SUANFARMA
Siflon Drugs
Shaanxi Dideu Group
Taizhou Crene Biotechnology
Zhejiang Gihi Chemicals
Vetpharma (Insud Pharma, S.L.U)
1 Market Overview
1.1 Product Overview and Scope of Veterinary Active Pharmaceutical Ingredients Manufacturing
1.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size and Forecast
1.3 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Veterinary Active Pharmaceutical Ingredients Manufacturing Share in Global Market, 2018-2029
1.4.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size: China VS Global, 2018-2029
1.5 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
1.5.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers
1.5.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints
1.5.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends
1.5.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Policy
2 Global Competitive Situation by Company
2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company (2018-2023)
2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Concentration Ratio
2.4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Mergers & Acquisitions, Expansion Plans
2.5 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company (2018-2023)
3.2 China Veterinary Active Pharmaceutical Ingredients Manufacturing Veterinary Active Pharmaceutical Ingredients Manufacturing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Veterinary Active Pharmaceutical Ingredients Manufacturing, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Chain
4.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Upstream Analysis
4.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Midstream Analysis
4.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Downstream Analysis
5 Sights by Type
5.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Classification
5.1.1 Antiparasitic
5.1.2 Anti-infectives
5.1.3 NSAIDs
5.1.4 Others
5.2 By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029
6 Sights by Application
6.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Segment by Application
6.1.1 Companion Animals
6.1.2 Production/Food Animals
6.2 By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
7.3 North America
7.3.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
7.4 Europe
7.4.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
7.6 South America
7.6.1 South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.3.2 By Company, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.4.2 By Company, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.5.2 By Company, China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
8.5.3 By Type, China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.6.2 By Company, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.7.2 By Company, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.9.2 By Company, India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
8.9.3 By Type, India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Alivira Animal Health Ltd.
9.1.1 Alivira Animal Health Ltd. Company Information, Head Office, Market Area and Industry Position
9.1.2 Alivira Animal Health Ltd. Company Profile and Main Business
9.1.3 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.1.4 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.1.5 Alivira Animal Health Ltd. Recent Developments
9.2 Chempro Pharma Private Ltd.
9.2.1 Chempro Pharma Private Ltd. Company Information, Head Office, Market Area and Industry Position
9.2.2 Chempro Pharma Private Ltd. Company Profile and Main Business
9.2.3 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.2.4 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.2.5 Chempro Pharma Private Ltd. Recent Developments
9.3 Excel Industries Ltd.
9.3.1 Excel Industries Ltd. Company Information, Head Office, Market Area and Industry Position
9.3.2 Excel Industries Ltd. Company Profile and Main Business
9.3.3 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.3.4 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.3.5 Excel Industries Ltd. Recent Developments
9.4 FIS - Fabbrica Italiana Sintetici S.p.A.
9.4.1 FIS - Fabbrica Italiana Sintetici S.p.A. Company Information, Head Office, Market Area and Industry Position
9.4.2 FIS - Fabbrica Italiana Sintetici S.p.A. Company Profile and Main Business
9.4.3 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.4.4 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.4.5 FIS - Fabbrica Italiana Sintetici S.p.A. Recent Developments
9.5 HIKAL Ltd.
9.5.1 HIKAL Ltd. Company Information, Head Office, Market Area and Industry Position
9.5.2 HIKAL Ltd. Company Profile and Main Business
9.5.3 HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.5.4 HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.5.5 HIKAL Ltd. Recent Developments
9.6 HuBei Masteam Bio-tech
9.6.1 HuBei Masteam Bio-tech Company Information, Head Office, Market Area and Industry Position
9.6.2 HuBei Masteam Bio-tech Company Profile and Main Business
9.6.3 HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.6.4 HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.6.5 HuBei Masteam Bio-tech Recent Developments
9.7 Hunan Huateng Pharmaceutical
9.7.1 Hunan Huateng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.7.2 Hunan Huateng Pharmaceutical Company Profile and Main Business
9.7.3 Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.7.4 Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.7.5 Hunan Huateng Pharmaceutical Recent Developments
9.8 Jiangsu Rivocean
9.8.1 Jiangsu Rivocean Company Information, Head Office, Market Area and Industry Position
9.8.2 Jiangsu Rivocean Company Profile and Main Business
9.8.3 Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.8.4 Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.8.5 Jiangsu Rivocean Recent Developments
9.9 Ofichem Group
9.9.1 Ofichem Group Company Information, Head Office, Market Area and Industry Position
9.9.2 Ofichem Group Company Profile and Main Business
9.9.3 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.9.4 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.9.5 Ofichem Group Recent Developments
9.10 Qilu Pharma Spain, S.A.
9.10.1 Qilu Pharma Spain, S.A. Company Information, Head Office, Market Area and Industry Position
9.10.2 Qilu Pharma Spain, S.A. Company Profile and Main Business
9.10.3 Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.10.4 Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.10.5 Qilu Pharma Spain, S.A. Recent Developments
9.11 Menadiona
9.11.1 Menadiona Company Information, Head Office, Market Area and Industry Position
9.11.2 Menadiona Company Profile and Main Business
9.11.3 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.11.4 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.11.5 Menadiona Recent Developments
9.12 Nissan Chemical
9.12.1 Nissan Chemical Company Information, Head Office, Market Area and Industry Position
9.12.2 Nissan Chemical Company Profile and Main Business
9.12.3 Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.12.4 Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.12.5 Nissan Chemical Recent Developments
9.13 SUANFARMA
9.13.1 SUANFARMA Company Information, Head Office, Market Area and Industry Position
9.13.2 SUANFARMA Company Profile and Main Business
9.13.3 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.13.4 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.13.5 SUANFARMA Recent Developments
9.14 Siflon Drugs
9.14.1 Siflon Drugs Company Information, Head Office, Market Area and Industry Position
9.14.2 Siflon Drugs Company Profile and Main Business
9.14.3 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.14.4 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.14.5 Siflon Drugs Recent Developments
9.15 Shaanxi Dideu Group
9.15.1 Shaanxi Dideu Group Company Information, Head Office, Market Area and Industry Position
9.15.2 Shaanxi Dideu Group Company Profile and Main Business
9.15.3 Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.15.4 Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.15.5 Shaanxi Dideu Group Recent Developments
9.16 Taizhou Crene Biotechnology
9.16.1 Taizhou Crene Biotechnology Company Information, Head Office, Market Area and Industry Position
9.16.2 Taizhou Crene Biotechnology Company Profile and Main Business
9.16.3 Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.16.4 Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.16.5 Taizhou Crene Biotechnology Recent Developments
9.17 Zhejiang Gihi Chemicals
9.17.1 Zhejiang Gihi Chemicals Company Information, Head Office, Market Area and Industry Position
9.17.2 Zhejiang Gihi Chemicals Company Profile and Main Business
9.17.3 Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.17.4 Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.17.5 Zhejiang Gihi Chemicals Recent Developments
9.18 Vetpharma (Insud Pharma, S.L.U)
9.18.1 Vetpharma (Insud Pharma, S.L.U) Company Information, Head Office, Market Area and Industry Position
9.18.2 Vetpharma (Insud Pharma, S.L.U) Company Profile and Main Business
9.18.3 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.18.4 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.18.5 Vetpharma (Insud Pharma, S.L.U) Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints
Table 3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends
Table 4. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Policy
Table 5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Company (2018-2023)
Table 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Mergers & Acquisitions, Expansion Plans
Table 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturers Product Type
Table 10. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company (2018-2023) & (US$ million)
Table 11. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Veterinary Active Pharmaceutical Ingredients Manufacturing Upstream (Raw Materials)
Table 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Typical Customers
Table 14. Veterinary Active Pharmaceutical Ingredients Manufacturing Typical Distributors
Table 15. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2029
Table 22. Alivira Animal Health Ltd. Company Information, Head Office, Market Area and Industry Position
Table 23. Alivira Animal Health Ltd. Company Profile and Main Business
Table 24. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 25. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 26. Alivira Animal Health Ltd. Recent Developments
Table 27. Chempro Pharma Private Ltd. Company Information, Head Office, Market Area and Industry Position
Table 28. Chempro Pharma Private Ltd. Company Profile and Main Business
Table 29. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 30. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 31. Chempro Pharma Private Ltd. Recent Developments
Table 32. Excel Industries Ltd. Company Information, Head Office, Market Area and Industry Position
Table 33. Excel Industries Ltd. Company Profile and Main Business
Table 34. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 35. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 36. Excel Industries Ltd. Recent Developments
Table 37. FIS - Fabbrica Italiana Sintetici S.p.A. Company Information, Head Office, Market Area and Industry Position
Table 38. FIS - Fabbrica Italiana Sintetici S.p.A. Company Profile and Main Business
Table 39. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 40. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 41. FIS - Fabbrica Italiana Sintetici S.p.A. Recent Developments
Table 42. HIKAL Ltd. Company Information, Head Office, Market Area and Industry Position
Table 43. HIKAL Ltd. Company Profile and Main Business
Table 44. HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 45. HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 46. HIKAL Ltd. Recent Developments
Table 47. HuBei Masteam Bio-tech Company Information, Head Office, Market Area and Industry Position
Table 48. HuBei Masteam Bio-tech Company Profile and Main Business
Table 49. HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 50. HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 51. HuBei Masteam Bio-tech Recent Developments
Table 52. Hunan Huateng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 53. Hunan Huateng Pharmaceutical Company Profile and Main Business
Table 54. Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 55. Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 56. Hunan Huateng Pharmaceutical Recent Developments
Table 57. Jiangsu Rivocean Company Information, Head Office, Market Area and Industry Position
Table 58. Jiangsu Rivocean Company Profile and Main Business
Table 59. Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 60. Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 61. Jiangsu Rivocean Recent Developments
Table 62. Ofichem Group Company Information, Head Office, Market Area and Industry Position
Table 63. Ofichem Group Company Profile and Main Business
Table 64. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 65. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 66. Ofichem Group Recent Developments
Table 67. Qilu Pharma Spain, S.A. Company Information, Head Office, Market Area and Industry Position
Table 68. Qilu Pharma Spain, S.A. Company Profile and Main Business
Table 69. Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 70. Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 71. Qilu Pharma Spain, S.A. Recent Developments
Table 72. Menadiona Company Information, Head Office, Market Area and Industry Position
Table 73. Menadiona Company Profile and Main Business
Table 74. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 75. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 76. Menadiona Recent Developments
Table 77. Nissan Chemical Company Information, Head Office, Market Area and Industry Position
Table 78. Nissan Chemical Company Profile and Main Business
Table 79. Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 80. Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 81. Nissan Chemical Recent Developments
Table 82. SUANFARMA Company Information, Head Office, Market Area and Industry Position
Table 83. SUANFARMA Company Profile and Main Business
Table 84. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 85. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 86. SUANFARMA Recent Developments
Table 87. Siflon Drugs Company Information, Head Office, Market Area and Industry Position
Table 88. Siflon Drugs Company Profile and Main Business
Table 89. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 90. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 91. Siflon Drugs Recent Developments
Table 92. Shaanxi Dideu Group Company Information, Head Office, Market Area and Industry Position
Table 93. Shaanxi Dideu Group Company Profile and Main Business
Table 94. Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 95. Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 96. Shaanxi Dideu Group Recent Developments
Table 97. Taizhou Crene Biotechnology Company Information, Head Office, Market Area and Industry Position
Table 98. Taizhou Crene Biotechnology Company Profile and Main Business
Table 99. Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 100. Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 101. Taizhou Crene Biotechnology Recent Developments
Table 102. Zhejiang Gihi Chemicals Company Information, Head Office, Market Area and Industry Position
Table 103. Zhejiang Gihi Chemicals Company Profile and Main Business
Table 104. Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 105. Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 106. Zhejiang Gihi Chemicals Recent Developments
Table 107. Vetpharma (Insud Pharma, S.L.U) Company Information, Head Office, Market Area and Industry Position
Table 108. Vetpharma (Insud Pharma, S.L.U) Company Profile and Main Business
Table 109. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
Table 110. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
Table 111. Vetpharma (Insud Pharma, S.L.U) Recent Developments
List of Figure
Figure 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Picture
Figure 2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share of Global
Figure 5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Veterinary Active Pharmaceutical Ingredients Manufacturing Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Chain
Figure 10. Antiparasitic
Figure 11. Anti-infectives
Figure 12. NSAIDs
Figure 13. Others
Figure 14. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, US$ Million
Figure 15. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2029
Figure 16. Companion Animals
Figure 17. Production/Food Animals
Figure 18. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2029
Figure 20. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2029
Figure 21. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
Figure 23. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
Figure 25. Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
Figure 27. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023
Figure 32. By Type, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 34. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023
Figure 36. By Type, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 38. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023
Figure 40. By Type, China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 42. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023
Figure 44. By Type, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 46. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023
Figure 48. By Type, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023
Figure 52. By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 54. India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023
Figure 56. By Type, India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Research Methodology:
Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|